<!DOCTYPE html SYSTEM "about:legacy-compat">
<html xmlns:ns0="http://www.w3.org/2001/XInclude" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"/>
    <title>DC Code - § 48–803.03. Dispensing of substitute drug products — conditions.</title>
    <meta property="st:title" content="&#xA7; 48&#x2013;803.03. Dispensing of substitute drug products &#x2014; conditions."/>
    <meta name="description" content="A simple, free browser for the Washington, DC Code"/>
    <meta name="viewport" content="width=device-width"/>
    <link href="https://fonts.googleapis.com/css?family=Open+Sans:400italic,700italic,400,700" rel="stylesheet" type="text/css"/>
    <link rel="stylesheet" type="text/css" href="/css/reset.css" media="screen"/>
    <link rel="stylesheet" type="text/css" href="/css/site.css" media="screen"/>
    <link rel="stylesheet" type="text/css" href="/css/body.css" media="screen"/>
    <link rel="stylesheet" type="text/css" href="/css/print.css" media="print"/>
    <link rel="stylesheet" type="text/css" href="/css/icons/style.css" media="screen"/>
    <script type="text/javascript">
            var _paq = _paq || [];
            _paq.push(['trackPageView']);
            _paq.push(['enableLinkTracking']);
            (function() {
              var u="//analytics.code.dccouncil.us/";
              _paq.push(['setTrackerUrl', u+'piwik.php']);
              _paq.push(['setSiteId', 1]);
              var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
              g.type='text/javascript'; g.async=true; g.defer=true; g.src=u+'piwik.js'; s.parentNode.insertBefore(g,s);
            })();

          window.searchHost = 'https://search.code.dccouncil.us';
          window.queryUrl = '/v1/search';
          </script>
    <noscript>
      <p>
        <img src="//analytics.code.dccouncil.us/piwik.php?idsite=1" style="border:0;" alt=""/>
      </p>
    </noscript>
  </head>
  <body>
    <header>
      <div class="container">
        <div class="right no-print search" id="search"> </div>
        <h1 id="sitename">
          <a href="/dc/council/code/">Code of the District of Columbia</a>
        </h1>
      </div>
    </header>
    <div class="main container">
      <div class="clearfix" style="width: 100%;">
        <div id="sidebar" class="col4 quiet">
          <h2>You Are Here</h2>
          <ul class="ancestors">
            <li>↪ <a href="/">D.C. Law Library</a></li>
            <li>↪ <a href="/dc/council/code/">Code of the District of Columbia</a></li>
            <li>↪ <a href="/dc/council/code/titles/48/">Title 48. Foods and Drugs.</a></li>
            <li>↪ <a href="/dc/council/code/titles/48/chapters/8/">Chapter 8. Prescription Drug Price Information.</a></li>
            <li>↪ <a href="/dc/council/code/titles/48/chapters/8/subchapters/III/">Subchapter III. Substitution of Therapeutically Equivalent Drugs.</a></li>
            <li>↪ § 48–803.03. Dispensing of substitute drug products — conditions.</li>
          </ul>
          <h2>Previous</h2>
          <p>
            <a class="internal-link" href="/dc/council/code/sections/48-803.02.html">§ 48–803.02. Dispensing of generically equivalent drug products.</a>
          </p>
          <h2>Next</h2>
          <p>
            <a class="internal-link" href="/dc/council/code/sections/48-803.03a.html">§ 48–803.03a. Dispensing of substitute drug products by pharmacists — notification of substitution.</a>
          </p>
          <h2>Publication Information</h2>
          <h3>Current through January 09, 2016</h3>
          <dl id="recency">
          <dt>Last codified D.C. Law:</dt>
          <dd>
            Law 21-46 effective January 09, 2016</dd>
          <dt>Last codified Emergency Law:</dt>
          <dd>
            Act 21-240 effective December 21, 2015</dd>
          <dt>Last codified Federal Law:</dt>
          <dd>
            Public Law 114-95 approved December 10, 2015</dd>
        </dl>
          <div class="cta">
            <p>
              <a href="mailto:code@dccouncil.us?subject=[ERROR]+/dc/council/code/sections/48-803.03.html">Report Error</a>
            </p>
            <p>
              <a href="mailto:code@dccouncil.us?subject=[FEEDBACK]+/dc/council/code/sections/48-803.03.html">Website Feedback</a>
            </p>
            <p>We cannot respond to questions regarding the law.</p>
          </div>
        </div>
        <div class="col8 body">
          <h1>§ 48–803.03. Dispensing of substitute drug products — conditions.</h1>
          <div class="toc"> </div>
          <div class="content">
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">A pharmacist shall not dispense a:</div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>Substitute drug product if the person purchasing the drug product or the patient for whom it is intended indicates a preference for the drug product actually prescribed;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>Generically equivalent drug product pursuant to § <a class="internal-link" href="/dc/council/code/sections/48-803.02.html">48-803.02</a> if:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>The prescriber writes on a prescription order, signed by the prescriber, in the prescriber’s own handwriting “dispense as written” or “D.A.W.” or a similar notation; provided, that checking or initialing a box preprinted or stamped on a prescription form shall not constitute an acceptable notation; or</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>The prescriber, by telephone, expressly indicates that the prescription is to be dispensed as communicated and this indication is noted in the pharmacist’s own handwriting in the manner provided in subparagraph (A) of this paragraph;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(3)</span>
                          <span class="level-num">(A)</span>
                          <span>Therapeutically equivalent drug product unless:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(i)</span>
                          <span class="level-num">(I)</span>
                          <span>The pharmacist or pharmacist’s agent obtains prior approval from the prescriber or the prescriber’s agent before the therapeutically equivalent drug product can be dispensed; or</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 5em">
                        <p>
                          <span class="level-num">(II)</span>
                          <span>The therapeutically equivalent drug product is included on the therapeutic interchange list and the endorsing prescriber has given consent to the Boards of Pharmacy and Medicine to permit therapeutic interchange without prior approval;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(ii)</span>
                          <span>The person purchasing the drug product provides consent to the therapeutic interchange;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(iii)</span>
                          <span>The therapeutically equivalent drug product does not have a higher cost to the purchaser than the originally prescribed drug product; provided, that the pharmacist may dispense a more expensive therapeutically equivalent drug product if consent is provided by the purchaser; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(iv)</span>
                          <span>The dispensing pharmacist, or pharmacist’s agent, has notified the prescriber or prescriber’s agent of the specific drug and dose dispensed.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>A pharmacist shall not dispense a therapeutically equivalent drug product for a prescription refill of an antipsychotic, antidepressant, chemotherapy, antiretroviral, or immunosuppressive drug but shall dispense the drug as prescribed.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/1-81.html">Sept. 10, 1976, D.C. Law 1-81, title III, § 303, 23 DCR 2460</a>; <a class="internal-link" href="/dc/council/laws/1-114.html">Apr. 7, 1977, D.C. Law 1-114, § 4(a), 23 DCR 8743</a>; <a class="internal-link" href="/dc/council/laws/18-118.html">Mar. 11, 2010, D.C. Law 18-118, § 2(c), 57 DCR 901</a>.)
    </div>
                      <div class="line subheading">Section References</div>
                      <div class="line" style="text-indent: 1.5em">This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/48-803.02.html">48-803.02</a>.</div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-733.</div>
                      <div class="line" style="text-indent: 1.5em">1973 Ed., § 33-833.</div>
                      <div class="line subheading">Effect of Amendments</div>
                      <div class="line" style="text-indent: 1.5em"><a class="internal-link" href="/dc/council/laws/18-118.html">D.C. Law 18-118</a> rewrote the section.</div>
                    </div>
                  </div>
          </div>
        </div>
      </div>
    </div>
    <footer>
      <div class="container center">
        <p>The codes and laws on this website are in the public domain.</p>
        <p>
              Please do not scrape. Instead, bulk download the <a href="https://github.com/dccouncil/dc-law-html">HTML</a> or <a href="https://github.com/dccouncil/dc-law-xml">XML</a>.
            </p>
      </div>
    </footer>
    <script type="text/javascript" src="/js/search.js"> </script>
  </body>
</html>
